Clinical Trial Update: Denileukin Diftitox in Treating Patients With Non-Hodgkin's Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating denileukin diftitox for lymphomas has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma

Drugs mentioned

• Denileukin diftitox (denileukin diftitox)

Snippet

Sponsor: Eastern Cooperative Oncology Group | Conditions: Lymphoma | Phase 2 | Status: COMPLETED